Large scale production and characterization of SARS‐CoV‐2 whole antigen for serological test development-Reference-Cited by-同舟云学术

Large scale production and characterization of SARS‐CoV‐2 whole antigen for serological test development

Published:2021-02-19 Issue:4 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Cerutti Helena¹²^ORCID,Ricci Veronica²³,Tesi Giulia¹²,Soldatini Claudia¹²,Castria Marinunzia¹²,Vaccaro Marco Natale²³,Tornesi Stefania²³,Toppi Simona²³,Verdiani Silvana²³,Brogi Alessandra¹²

Affiliation:

1. R&D Site: Via Fiorentina 1‐ c/o Toscana Life Sciences Siena Italy

2. Diesse Diagnostica Senese SpA Siena Italy

3. Production Site: Via delle Rose Monteriggioni Italy

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23735

Reference23 articles.

1. World Health Organization.Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection[published online ahead of print January 21 2020].https://apps.who.int/iris/bitstream/handle/10665/330374/WHO‐2019‐nCoV‐laboratory‐2020.1‐eng.pdf. Accessed November 2020.

2. WHO.Weekly operational update on COVID‐19 ‐ 30 October 2020.

3. A Review of Coronavirus Disease-2019 (COVID-19)

4. Coronaviruses post-SARS: update on replication and pathogenesis

5. Emerging coronaviruses: Genome structure, replication, and pathogenesis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein characterization of an Indonesian isolate of foot and mouth disease virus inactivated with formaldehyde and binary ethylenimine;Veterinary World;2024-08

2. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training;Journal of Virological Methods;2023-07

3. Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials;Viruses;2023-06-30

4. SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy;Viruses;2022-06-30

5. A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies;Journal of Clinical Virology;2022-02